$5.32
Today
as of Sep 4, 16:45 ET
Last 30 days
Recent Press Releases & News
Update: Alvotech Shares Rise After FDA Accepts Biologics License Application for AVT80
Alvotech Says FDA Accepted Biologics License Application for AVT80
Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations
Overview
52-week range
$2.94
$9.25
38% of range
Avg surprise (last 3)
+143.7%
Avg reaction (last 2)
+0.8%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $-0.09 | $-0.07 | -28.6% | -125.7% | +2.0% | earnings |
| Wed Aug 13, 2025 | Jun/2025 | $0.14 | $-0.26 | +153.8% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $0.35 | $-0.17 | +305.9% | — | -0.4% | earnings |
Implied volatility — last 90 days
No IV snapshots yet for ALVO.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.